BackAsensus Surgical Overview

Asensus Surgical Research & Development

Research & Development expenses for ASXC.

Quarterly R&D Expenses

$7.63M
↓ 15.02% YoY

As of Jun 30, 2024

Annual R&D Expenses (TTM)

$33.63M
↓ 2.19% YoY

Trailing 12 months ending Jun 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin